Global Rectal Mesalazine Market Growth (Status and Outlook) 2026-2032

April 2026 | 76 pages | ID: G85B22C88892EN
LP Information

Abstracts

The global Rectal Mesalazine market size is predicted to grow from US$ 83.62 million in 2025 to US$ 108 million in 2032; it is expected to grow at a CAGR of 3.7% from 2026 to 2032.

Rectal mesalazine, also known as rectal 5-aminosalicylic acid (5-ASA) or rectal mesalamine, is a medication used to treat certain inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn's disease. It is available in various forms, including suppositories and enemas, and is administered rectally.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the ?Rectal Mesalazine Industry Forecast? looks at past sales and reviews total world Rectal Mesalazine sales in 2025, providing a comprehensive analysis by region and market sector of projected Rectal Mesalazine sales for 2026 through 2032. With Rectal Mesalazine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rectal Mesalazine industry.

This Insight Report provides a comprehensive analysis of the global Rectal Mesalazine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Rectal Mesalazine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Rectal Mesalazine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rectal Mesalazine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rectal Mesalazine.

This report presents a comprehensive overview, market shares, and growth opportunities of Rectal Mesalazine market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Suppository
• Enema

Segmentation by Application:

• Ulcerative Colitis
• Crohn's Disease
• Inflammatory Bowel Disease

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Ferring Global
• AbbVie
• Reid-Rowell
• Dr. Falk Pharma UK
• Alaven Pharmaceutical

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Rectal Mesalazine Market Size (2021-2032)
  2.1.2 Rectal Mesalazine Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Rectal Mesalazine by Country/Region (2021, 2025 & 2032)
2.2 Rectal Mesalazine Segment by Type
  2.2.1 Suppository
  2.2.2 Enema
  2.2.3 Rectal Mesalazine Market Size by Type
    2.2.3.1 Rectal Mesalazine Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Rectal Mesalazine Market Size Market Share by Type (2021-2026)
2.3 Rectal Mesalazine Segment by Application
  2.3.1 Ulcerative Colitis
  2.3.2 Crohn's Disease
  2.3.3 Inflammatory Bowel Disease
  2.3.4 Rectal Mesalazine Market Size by Application
    2.3.4.1 Rectal Mesalazine Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Rectal Mesalazine Market Size Market Share by Application (2021-2026)

3 RECTAL MESALAZINE MARKET SIZE BY PLAYER

3.1 Rectal Mesalazine Market Size Market Share by Player
  3.1.1 Global Rectal Mesalazine Revenue by Player (2021-2026)
  3.1.2 Global Rectal Mesalazine Revenue Market Share by Player (2021-2026)
3.2 Global Rectal Mesalazine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RECTAL MESALAZINE BY REGION

4.1 Rectal Mesalazine Market Size by Region (2021-2026)
4.2 Global Rectal Mesalazine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Rectal Mesalazine Market Size Growth (2021-2026)
4.4 APAC Rectal Mesalazine Market Size Growth (2021-2026)
4.5 Europe Rectal Mesalazine Market Size Growth (2021-2026)
4.6 Middle East & Africa Rectal Mesalazine Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Rectal Mesalazine Market Size by Country (2021-2026)
5.2 Americas Rectal Mesalazine Market Size by Type (2021-2026)
5.3 Americas Rectal Mesalazine Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Rectal Mesalazine Market Size by Region (2021-2026)
6.2 APAC Rectal Mesalazine Market Size by Type (2021-2026)
6.3 APAC Rectal Mesalazine Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Rectal Mesalazine Market Size by Country (2021-2026)
7.2 Europe Rectal Mesalazine Market Size by Type (2021-2026)
7.3 Europe Rectal Mesalazine Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Rectal Mesalazine by Region (2021-2026)
8.2 Middle East & Africa Rectal Mesalazine Market Size by Type (2021-2026)
8.3 Middle East & Africa Rectal Mesalazine Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RECTAL MESALAZINE MARKET FORECAST

10.1 Global Rectal Mesalazine Forecast by Region (2027-2032)
  10.1.1 Global Rectal Mesalazine Forecast by Region (2027-2032)
  10.1.2 Americas Rectal Mesalazine Forecast
  10.1.3 APAC Rectal Mesalazine Forecast
  10.1.4 Europe Rectal Mesalazine Forecast
  10.1.5 Middle East & Africa Rectal Mesalazine Forecast
10.2 Americas Rectal Mesalazine Forecast by Country (2027-2032)
  10.2.1 United States Market Rectal Mesalazine Forecast
  10.2.2 Canada Market Rectal Mesalazine Forecast
  10.2.3 Mexico Market Rectal Mesalazine Forecast
  10.2.4 Brazil Market Rectal Mesalazine Forecast
10.3 APAC Rectal Mesalazine Forecast by Region (2027-2032)
  10.3.1 China Rectal Mesalazine Market Forecast
  10.3.2 Japan Market Rectal Mesalazine Forecast
  10.3.3 Korea Market Rectal Mesalazine Forecast
  10.3.4 Southeast Asia Market Rectal Mesalazine Forecast
  10.3.5 India Market Rectal Mesalazine Forecast
  10.3.6 Australia Market Rectal Mesalazine Forecast
10.4 Europe Rectal Mesalazine Forecast by Country (2027-2032)
  10.4.1 Germany Market Rectal Mesalazine Forecast
  10.4.2 France Market Rectal Mesalazine Forecast
  10.4.3 UK Market Rectal Mesalazine Forecast
  10.4.4 Italy Market Rectal Mesalazine Forecast
  10.4.5 Russia Market Rectal Mesalazine Forecast
10.5 Middle East & Africa Rectal Mesalazine Forecast by Region (2027-2032)
  10.5.1 Egypt Market Rectal Mesalazine Forecast
  10.5.2 South Africa Market Rectal Mesalazine Forecast
  10.5.3 Israel Market Rectal Mesalazine Forecast
  10.5.4 Turkey Market Rectal Mesalazine Forecast
10.6 Global Rectal Mesalazine Forecast by Type (2027-2032)
10.7 Global Rectal Mesalazine Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Rectal Mesalazine Forecast

11 KEY PLAYERS ANALYSIS

11.1 Ferring Global
  11.1.1 Ferring Global Company Information
  11.1.2 Ferring Global Rectal Mesalazine Product Offered
  11.1.3 Ferring Global Rectal Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Ferring Global Main Business Overview
  11.1.5 Ferring Global Latest Developments
11.2 AbbVie
  11.2.1 AbbVie Company Information
  11.2.2 AbbVie Rectal Mesalazine Product Offered
  11.2.3 AbbVie Rectal Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 AbbVie Main Business Overview
  11.2.5 AbbVie Latest Developments
11.3 Reid-Rowell
  11.3.1 Reid-Rowell Company Information
  11.3.2 Reid-Rowell Rectal Mesalazine Product Offered
  11.3.3 Reid-Rowell Rectal Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Reid-Rowell Main Business Overview
  11.3.5 Reid-Rowell Latest Developments
11.4 Dr. Falk Pharma UK
  11.4.1 Dr. Falk Pharma UK Company Information
  11.4.2 Dr. Falk Pharma UK Rectal Mesalazine Product Offered
  11.4.3 Dr. Falk Pharma UK Rectal Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Dr. Falk Pharma UK Main Business Overview
  11.4.5 Dr. Falk Pharma UK Latest Developments
11.5 Alaven Pharmaceutical
  11.5.1 Alaven Pharmaceutical Company Information
  11.5.2 Alaven Pharmaceutical Rectal Mesalazine Product Offered
  11.5.3 Alaven Pharmaceutical Rectal Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Alaven Pharmaceutical Main Business Overview
  11.5.5 Alaven Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Rectal Mesalazine Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Rectal Mesalazine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Suppository
Table 4. Major Players of Enema
Table 5. Rectal Mesalazine Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Rectal Mesalazine Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Rectal Mesalazine Market Size Market Share by Type (2021-2026)
Table 8. Rectal Mesalazine Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Rectal Mesalazine Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Rectal Mesalazine Market Size Market Share by Application (2021-2026)
Table 11. Global Rectal Mesalazine Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Rectal Mesalazine Revenue Market Share by Player (2021-2026)
Table 13. Rectal Mesalazine Key Players Head office and Products Offered
Table 14. Rectal Mesalazine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Rectal Mesalazine Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Rectal Mesalazine Market Size Market Share by Region (2021-2026)
Table 19. Global Rectal Mesalazine Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Rectal Mesalazine Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Rectal Mesalazine Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Rectal Mesalazine Market Size Market Share by Country (2021-2026)
Table 23. Americas Rectal Mesalazine Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Rectal Mesalazine Market Size Market Share by Type (2021-2026)
Table 25. Americas Rectal Mesalazine Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Rectal Mesalazine Market Size Market Share by Application (2021-2026)
Table 27. APAC Rectal Mesalazine Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Rectal Mesalazine Market Size Market Share by Region (2021-2026)
Table 29. APAC Rectal Mesalazine Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Rectal Mesalazine Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Rectal Mesalazine Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Rectal Mesalazine Market Size Market Share by Country (2021-2026)
Table 33. Europe Rectal Mesalazine Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Rectal Mesalazine Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Rectal Mesalazine Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Rectal Mesalazine Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Rectal Mesalazine Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Rectal Mesalazine
Table 39. Key Market Challenges & Risks of Rectal Mesalazine
Table 40. Key Industry Trends of Rectal Mesalazine
Table 41. Global Rectal Mesalazine Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Rectal Mesalazine Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Rectal Mesalazine Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Rectal Mesalazine Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Ferring Global Details, Company Type, Rectal Mesalazine Area Served and Its Competitors
Table 46. Ferring Global Rectal Mesalazine Product Offered
Table 47. Ferring Global Rectal Mesalazine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Ferring Global Main Business
Table 49. Ferring Global Latest Developments
Table 50. AbbVie Details, Company Type, Rectal Mesalazine Area Served and Its Competitors
Table 51. AbbVie Rectal Mesalazine Product Offered
Table 52. AbbVie Rectal Mesalazine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. AbbVie Main Business
Table 54. AbbVie Latest Developments
Table 55. Reid-Rowell Details, Company Type, Rectal Mesalazine Area Served and Its Competitors
Table 56. Reid-Rowell Rectal Mesalazine Product Offered
Table 57. Reid-Rowell Rectal Mesalazine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Reid-Rowell Main Business
Table 59. Reid-Rowell Latest Developments
Table 60. Dr. Falk Pharma UK Details, Company Type, Rectal Mesalazine Area Served and Its Competitors
Table 61. Dr. Falk Pharma UK Rectal Mesalazine Product Offered
Table 62. Dr. Falk Pharma UK Rectal Mesalazine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Dr. Falk Pharma UK Main Business
Table 64. Dr. Falk Pharma UK Latest Developments
Table 65. Alaven Pharmaceutical Details, Company Type, Rectal Mesalazine Area Served and Its Competitors
Table 66. Alaven Pharmaceutical Rectal Mesalazine Product Offered
Table 67. Alaven Pharmaceutical Rectal Mesalazine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Alaven Pharmaceutical Main Business
Table 69. Alaven Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Rectal Mesalazine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rectal Mesalazine Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Rectal Mesalazine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Rectal Mesalazine Sales Market Share by Country/Region (2025)
Figure 8. Rectal Mesalazine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Rectal Mesalazine Market Size Market Share by Type in 2025
Figure 10. Rectal Mesalazine in Ulcerative Colitis
Figure 11. Global Rectal Mesalazine Market: Ulcerative Colitis (2021-2026) & ($ millions)
Figure 12. Rectal Mesalazine in Crohn's Disease
Figure 13. Global Rectal Mesalazine Market: Crohn's Disease (2021-2026) & ($ millions)
Figure 14. Rectal Mesalazine in Inflammatory Bowel Disease
Figure 15. Global Rectal Mesalazine Market: Inflammatory Bowel Disease (2021-2026) & ($ millions)
Figure 16. Global Rectal Mesalazine Market Size Market Share by Application in 2025
Figure 17. Global Rectal Mesalazine Revenue Market Share by Player in 2025
Figure 18. Global Rectal Mesalazine Market Size Market Share by Region (2021-2026)
Figure 19. Americas Rectal Mesalazine Market Size 2021-2026 ($ millions)
Figure 20. APAC Rectal Mesalazine Market Size 2021-2026 ($ millions)
Figure 21. Europe Rectal Mesalazine Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Rectal Mesalazine Market Size 2021-2026 ($ millions)
Figure 23. Americas Rectal Mesalazine Value Market Share by Country in 2025
Figure 24. United States Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Rectal Mesalazine Market Size Market Share by Region in 2025
Figure 29. APAC Rectal Mesalazine Market Size Market Share by Type (2021-2026)
Figure 30. APAC Rectal Mesalazine Market Size Market Share by Application (2021-2026)
Figure 31. China Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 35. India Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Rectal Mesalazine Market Size Market Share by Country in 2025
Figure 38. Europe Rectal Mesalazine Market Size Market Share by Type (2021-2026)
Figure 39. Europe Rectal Mesalazine Market Size Market Share by Application (2021-2026)
Figure 40. Germany Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 41. France Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Rectal Mesalazine Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Rectal Mesalazine Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Rectal Mesalazine Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Rectal Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 54. APAC Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 55. Europe Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 57. United States Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 58. Canada Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 59. Mexico Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 60. Brazil Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 61. China Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 62. Japan Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 63. Korea Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 65. India Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 66. Australia Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 67. Germany Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 68. France Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 69. UK Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 70. Italy Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 71. Russia Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 72. Egypt Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 73. South Africa Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 74. Israel Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 75. Turkey Rectal Mesalazine Market Size 2027-2032 ($ millions)
Figure 76. Global Rectal Mesalazine Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Rectal Mesalazine Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Rectal Mesalazine Market Size 2027-2032 ($ millions)